Comparison of lenvatinib plus pembrolizumab versus firstline systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: A real-world retrospective study

被引：0
|
作者：
Yang, Z. [1 ]
Hu, D. [1 ]
Chen, M. [1 ]
机构：
[1] Sun Yat Sen Univ, Dept Liver Surg, Canc Ctr, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.449
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
306P
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [1] Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study
    Yang, Zhenyun
    Wu, Weijie
    Hu, Zhiwen
    Fu, Yizhen
    Hu, Zili
    Pan, Yangxun
    Wang, Juncheng
    Chen, Jinbin
    Zhou, Zhongguo
    Zhang, Yaojun
    Chen, Minshan
    Hu, Dandan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [2] Real-world outcomes of chemotherapy plus immune checkpoint inhibitors versus chemotherapy alone in advanced, unresectable, and recurrent intrahepatic cholangiocarcinoma
    Madzikatire, Tinotenda Blessing
    Heng, Shan
    Gu, HongYi
    Shan, YunFeng
    Lin, EnHua
    Banda, Joshua
    Debora, Asta
    Madziva, Brandon Anotida
    Bowa, Mutale Jaeste
    Mudhuri, Munyaradzi Godfrey
    Bwalya, Canol
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative optionfor advanced unresectable intrahepatic cholangiocarcinoma: A retrospective real-world study
    Dai, B.
    Dong, Z.
    Sui, C.
    Wang, K.
    Geng, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S667 - S667
  • [4] Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study
    Dong, Zhitao
    Sui, Chengjun
    Lu, Jiongjiong
    Guo, Junwu
    Duan, Kecai
    Wang, Kui
    Geng, Li
    Dai, Binghua
    Yang, Jiamei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study
    Zheng, Zhikai
    Wang, Jiongliang
    Wu, Tianqing
    He, Minrui
    Pan, Yangxun
    Wang, Juncheng
    Chen, Jinbin
    Hu, Dandan
    Xu, Li
    Zhang, Yaojun
    Chen, Minshan
    Zhou, Zhongguo
    INTERNATIONAL JOURNAL OF SURGERY, 2025, 111 (01) : 1552 - 1557
  • [6] Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis
    Chao, Jiashuo
    Wang, Shanshan
    Wang, Hao
    Zhang, Nan
    Wang, Yunchao
    Yang, Xu
    Zhu, Chengpei
    Ning, Cong
    Zhang, Xinmu
    Xue, Jingnan
    Zhang, Longhao
    Piao, Mingjian
    Wang, Mingming
    Yang, Xiaobo
    Lu, Ling
    Zhao, Haitao
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (11) : 3717 - 3726
  • [7] Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study
    Wang, Shanshan
    Chao, Jiashuo
    Wang, Hao
    Li, Shuofeng
    Wang, Yunchao
    Zhu, Chengpei
    Zhang, Nan
    Piao, Mingjian
    Yang, Xu
    Liu, Kai
    Xun, Ziyu
    Sang, Xinting
    Yang, Xiaobo
    Duan, Weidong
    Zhao, Haitao
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [8] Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis
    Jiashuo Chao
    Shanshan Wang
    Hao Wang
    Nan Zhang
    Yunchao Wang
    Xu Yang
    Chengpei Zhu
    Cong Ning
    Xinmu Zhang
    Jingnan Xue
    Longhao Zhang
    Mingjian Piao
    Mingming Wang
    Xiaobo Yang
    Ling Lu
    Haitao Zhao
    Cancer Immunology, Immunotherapy, 2023, 72 : 3717 - 3726
  • [9] Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study
    Nan Jiang
    Ze Zhang
    Xiaoxv Yin
    Huaiming Qiu
    Weipeng Yan
    Yonghong Hao
    Wenhua Yang
    Hualing Li
    Anhui Xu
    Ketao Mu
    La radiologia medica, 2024, 129 : 631 - 642
  • [10] Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study
    Jiang, Nan
    Zhang, Ze
    Yin, Xiaoxv
    Qiu, Huaiming
    Yan, Weipeng
    Hao, Yonghong
    Yang, Wenhua
    Li, Hualing
    Xu, Anhui
    Mu, Ketao
    RADIOLOGIA MEDICA, 2024, 129 (04): : 631 - 642
12345